Patent-Pending Provinal™ Receives GRAS
In the last few years, Tersus Pharmaceutical, LLC has taken all the right steps to prepare for the launch of Provinal™. Chief among them was securing the services of the reputable AIBMR Life Sciences, Inc. group to certify the purified palmitoleic acid as generally regarded as safe. The board unanimously concluded the intended use of Provinal™ as a food ingredient is indeed GRAS. Additionally, Tersus has filed extensive palmitoleic acid use patents expected to be issued in the near future. This solid foundation will give brands and consumers alike the confidence to develop a successful product in the global marketplace.
Provinal™ Boasts HDL Cholesterol Levels 85%
In a 2011 randomized double blind placebo controlled clinical study conducted on behalf of Tersus Pharmaceutical, LLC by the Cleveland Clinic Heart and Vascular Institute, it was concluded that palmitoleic acid can significantly boost HDL cholesterol levels and reduce cholesterol deposition (plaque buildup). The study featured ApoE mice (considered the “gold standard” in modeling human atherosclerosis) and was modeled after similar studies conducted for major pharmaceutical drugs. The mice with a diet supplemented with palmitoleic acid showed an increase in HDL cholesterol levels of 40-90% while 100% of these mice exhibited a consistent anti-atherogenic effect (as measured by the aortic root lesion area). Additional studies are warranted, however based on these results, palmitoleic acid could provide a greater boost to HDL cholesterol levels than any other known natural product, including niacin - without flushing or other negative side effects.
